Beijing, China

Xinle Wu

USPTO Granted Patents = 2 

Average Co-Inventor Count = 6.9

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Innovations of Xinle Wu in Biopharmaceuticals

Introduction

Xinle Wu is a prominent inventor based in Beijing, China, known for his contributions to the field of biopharmaceuticals. With a total of two patents to his name, he has made significant strides in developing innovative therapeutic solutions.

Latest Patents

Xinle Wu's latest patents include groundbreaking work on polypeptide conjugates and methods of use. The first patent focuses on polypeptide conjugates comprising a GLP-1 receptor agonist and a peptide linker, along with pharmaceutical compositions that utilize these conjugates for treating various diseases. The second patent presents conjugates of fusion proteins of GLP-1 and FGF21, which also includes pharmaceutical compositions and methods for treating diseases.

Career Highlights

Xinle Wu is currently associated with Beijing Ql Biopharmaceutical Co., Ltd., where he continues to push the boundaries of biopharmaceutical research and development. His work is instrumental in advancing therapeutic options for patients.

Collaborations

Some of his notable coworkers include Yuanyuan Zhang and Haixia Zou, who contribute to the innovative environment at Beijing Ql Biopharmaceutical Co., Ltd.

Conclusion

Xinle Wu's innovative work in the field of biopharmaceuticals showcases his commitment to improving healthcare through advanced therapeutic solutions. His patents reflect a deep understanding of biochemistry and a dedication to addressing medical challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…